Gene: SKP2
Official Full Name: S-phase kinase associated protein 2provided by HGNC
Gene Summary: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbls class; in addition to an F-box, this protein contains 10 tandem leucine-rich repeats. This protein is an essential element of the cyclin A-CDK2 S-phase kinase. It specifically recognizes phosphorylated cyclin-dependent kinase inhibitor 1B (CDKN1B, also referred to as p27 or KIP1) predominantly in S phase and interacts with S-phase kinase-associated protein 1 (SKP1 or p19). In addition, this gene is established as a protooncogene causally involved in the pathogenesis of lymphomas. Alternative splicing of this gene generates three transcript variants encoding different isoforms. [provided by RefSeq, Jul 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00539 | SKP2 Knockout cell line (HeLa) | Human | SKP2 | 1:3~1:6 | Negative | Online Inquiry |
KO09170 | SKP2 Knockout cell line (HCT 116) | Human | SKP2 | 1:2~1:4 | Negative | Online Inquiry |
KO09171 | SKP2 Knockout cell line (HEK293) | Human | SKP2 | 1:3~1:6 | Negative | Online Inquiry |
KO09172 | SKP2 Knockout cell line (A549) | Human | SKP2 | 1:3~1:4 | Negative | Online Inquiry |
SKP2 Gene Knockout Cell Lines represent a groundbreaking tool in molecular biology research, specifically designed to enhance the study of cell cycle regulation, tumorigenesis, and the mechanisms of cell growth. These cell lines are engineered to have a targeted deletion of the SKP2 gene, which encodes a key component of the SCF (SKP1-Cullin-F-box) ubiquitin ligase complex that plays a significant role in promoting cell cycle progression by regulating the degradation of cyclin-dependent kinase inhibitors. By removing SKP2's function, researchers can elucidate its contributions to cellular processes such as proliferation, differentiation, and apoptosis.
The primary mechanism of action for these knockout cell lines involves the disruption of the SKP2-mediated ubiquitination pathway, allowing for the investigation of downstream effects on cell cycle regulators like p27Kip1. By employing these cell lines, researchers can effectively model the consequences of SKP2 loss in various cancer contexts, providing valuable insights into tumor biology and potential therapeutic targets.
In both research and clinical settings, the utilization of SKP2 Gene Knockout Cell Lines is of immense importance. They serve as an invaluable resource for understanding cancer progression, screening for new anticancer drugs, and developing pharmacological interventions that specifically target the aberrant cell cycle regulation found in many malignancies.
The advantages of using our SKP2 Gene Knockout Cell Lines include their high specificity, reproducibility, and the comprehensive support provided with each product. Compared to alternative models, our cell lines offer superior reliability and ease of use, allowing for more efficient experimental design and execution.
For researchers and clinicians focused on advancing cancer therapy and understanding cell cycle dynamics, the ability to create precise models of gene function is invaluable. Our SKP2 Gene Knockout Cell Lines facilitate such advancements, equipping scientists with the necessary tools to drive forward their research objectives.
With extensive expertise in the field of genetic engineering and a commitment to quality, our company is dedicated to providing superior biological products that empower researchers and drive innovation in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.